GROUP 1 [PTV dose: 78 Gy (39 fractions)] | |||
ROI | Parameter | Objective | Max Score |
PTV | CI (isodose50%) | >0.8 | 20 |
Rectum | V65Gy [%] | <25% | 30 |
Rectum | V75Gy [%] | <15% | 30 |
Rectum | Average Dose [Gy] | <60 Gy | 50 |
Bladder | V70Gy [%] | <35% | 30 |
Bladder | Average Dose [Gy] | <40 Gy | 50 |
Left Femoral Head | Average Dose [Gy] | <52 Gy | 10 |
Right Femoral Head | Average Dose [Gy] | <52 Gy | 10 |
Penile Bulb | Average Dose [Gy] | <52 Gy | 5 |
Total Score |
|
| 235 |
GROUP 2 [PTV1 dose: 70.2 Gy and PTV2 dose: 61.1 Gy (26 fractions)] | |||
ROI | Parameter | Objective | Max Score |
PTV1.2 | CI (isodose 50%) | >0.8 | 20 |
Rectum | V58Gy [%] | <25% | 30 |
Rectum | V67Gy [%] | <15% | 30 |
Rectum | Average Dose [Gy] | <60 Gy | 50 |
Bladder | V64Gy [%] | <35% | 30 |
Bladder | Average Dose [Gy] | <40 Gy | 50 |
Left Femoral Head | Average Dose [Gy] | <44 Gy | 30 |
Right Femoral Head | Average Dose [Gy] | <44 Gy | 30 |
Penile Bulb | Average Dose [Gy] | <52 Gy | 5 |
Total Score |
|
| 235 |